Robyn Neblett Fanfair.

Robyn Neblett Fanfair, M.D., M .P.H., Kaitlin Benedict, M.P.H., John Bos, M.P.H., Sarah D. Bennett, M.D., M.P.H., Yi-Chun Lo, M.D., Tolu Adebanjo, M.D., M.P.H., Kizee Etienne, M.P.H., Eszter Deak, Ph.D., M.P.H., Gordana Derado, Ph.D., Wun-Ju Shieh, M.D., Ph.D., M.P.H., Clifton Drew, D.V.M., Ph.D., Sherif Zaki, M.D., Ph.D., David Sugerman, M.D., M.P.H., Lalitha Gade, M.Pharm., Elizabeth H.

A different intensity of ultrafiltration may have led to more fluid loss in the ultrafiltration group; however, the effect of a different intensity on renal outcomes and function is unknown. Finally, the outcomes of the strategies tested here may not connect with other patient populations with acute decompensated heart failing, such as for example patients with less severe cardiorenal syndrome. In summary, we conducted a randomized trial involving patients hospitalized for acute decompensated heart failure, worsened renal function, and persistent congestion. We found that the usage of a stepped pharmacologic-therapy algorithm was more advanced than a technique of ultrafiltration for the preservation of renal function, with the quantity of weight reduction at 96 hours related with both approaches.